GeneSight® GUIDED Study Published in the Journal of Psychiatric Research
Go back to GeneSight® GUIDED Study Published in the Journal of Psychiatric Research| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 3.14 -0.04 (1.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.18 | 52 Week High | $45.34 | |||
| Open | $3.11 | 52 Week Low | $15.92 | |||
| Day High | $3.16 | P/E | 1.35 | |||
| Day Low | $3.09 | EPS | $2.33 | |||
| Volume | 272,842 | |||||

